| Name | Title | Contact Details |
|---|
Vendavo is a global enterprise software company that focuses on commercial excellence solutions for the manufacturing and distribution sectors. Established in 1998, Vendavo serves over 200 customers worldwide and employs around 500 people. The company aims to enhance pricing strategies, sales effectiveness, and profitability through data-driven insights. Vendavo offers a range of services, including pricing optimization tools, sales effectiveness solutions, and comprehensive rebate and channel management. Their profitability analytics provide AI-driven insights to help businesses identify revenue leakage and improve margins. The company reports significant customer impact, with clients experiencing annual revenue lifts of 1-3% and margin improvements of 10-30%. Vendavos solutions are tailored for industries such as manufacturing, distribution, consumer goods, high-tech, and life sciences. With a strong emphasis on innovation, Vendavo integrates various commercial processes into streamlined workflows. The company continues to grow strategically, exemplified by its acquisition of Market Medium in 2022, which enhanced its rebate management capabilities.
Thrive Companies revives neglected land for imaginative and collaborative spaces. We create communities to help people Thrive.
Denali Therapeutics is a clinical-stage biopharmaceutical company based in South San Francisco, California. The company focuses on developing therapies for neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, as well as lysosomal storage disorders like Hunter syndrome. Denali employs around 422 professionals and utilizes proprietary blood-brain barrier transport technologies to meet the medical needs of patients with brain-related disorders. Denalis innovative approach includes four engineered transport vehicle systems: Enzyme Transport Vehicle (ETV), Antibody Transport Vehicle (ATV), Protein Transport Vehicle (PTV), and Oligonucleotide Transport Vehicle (OTV). These technologies enable the delivery of various therapeutic agents to the brain. The company collaborates with major pharmaceutical partners, including Sanofi, AbbVie, and Takeda, to enhance the development of its pipeline products, which include DNL310 for Hunter syndrome and DNL151 for Parkinson’s disease. Denalis mission is to advance therapies that address the underlying causes of neurodegeneration, emphasizing a commitment to rigorous science and patient-focused innovation.
The RighTime Company is a Miami, FL-based company in the Business Services sector.